A Review Of GW7647
These trials confirmed clinically substantial pharmacokinetic interactions [7] characterized by a decrease within the clearance from the anticancer drug and hence greater exposure. The interpretation of subsequent stage II and III clinical trials was difficult because it was not possible to administer exactly the same dose of chemotherapy while in